Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer

Laure Dossus, Federico Canzian, Rudolf Kaaks, Abdelhamid Boumertit and Elisabete Weiderpass
Laure Dossus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Canzian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolf Kaaks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdelhamid Boumertit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabete Weiderpass
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-06-0215 Published July 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    Association of PGR polymorphism +331G/A with endometrial cancer risk: odds ratio (95% confidence interval)

    CasesControlsCrudeAdjusted for age
    Noncarriers of +331A allele2552891.001.00
    Carriers of +331A allele20250.91 (0.49-1.67)1.04 (0.56-1.93)
  • Table 2.

    Interaction between PGR polymorphism +331G/A and risk factors for endometrial cancer: odds ratio (95% confidence interval) for endometrial cancer risk

    Noncarriers of +331A alleleCarriers of +331A allelePinteraction
    BMI < 251.001.33 (0.46-3.90)
    25 ≤ BMI ≤ 281.20 (0.76-1.91)1.67 (0.49-5.66)
    BMI > 282.27 (1.48-3.47)1.11 (0.36-3.45)0.35
    Non-HRT users1.001.03 (0.42-2.55)
    HRT users1.79 (1.25-2.57)1.81 (0.76-4.33)0.96
    • Abbreviations: BMI, body mass index; HRT, hormone replacement therapy.

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 15 (7)
July 2006
Volume 15, Issue 7
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer
Laure Dossus, Federico Canzian, Rudolf Kaaks, Abdelhamid Boumertit and Elisabete Weiderpass
Cancer Epidemiol Biomarkers Prev July 1 2006 (15) (7) 1415-1416; DOI: 10.1158/1055-9965.EPI-06-0215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer
Laure Dossus, Federico Canzian, Rudolf Kaaks, Abdelhamid Boumertit and Elisabete Weiderpass
Cancer Epidemiol Biomarkers Prev July 1 2006 (15) (7) 1415-1416; DOI: 10.1158/1055-9965.EPI-06-0215
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and Methods
    • Results and Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement